Tian'an Pharmaceutical Co., Ltd.
TNPH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $143 | $8 | $0 |
| % Growth | -100% | 1,804.5% | – | – |
| Cost of Goods Sold | $0 | $75 | $0 | $0 |
| Gross Profit | $0 | $68 | $8 | $0 |
| % Margin | – | 47.3% | 100% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $18 | $78 | $41 | $31 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $18 | $78 | $41 | $31 |
| Operating Income | -$18 | -$11 | -$33 | -$31 |
| % Margin | – | -7.5% | -446% | – |
| Other Income/Exp. Net | $0 | $0 | $13 | $0 |
| Pre-Tax Income | -$1 | -$10 | -$20 | -$31 |
| Tax Expense | $0 | $1 | $0 | $0 |
| Net Income | -$1 | -$16 | -$20 | -$31 |
| % Margin | – | -11.2% | -272.7% | – |
| EPS | 0 | 0 | -0 | -0.001 |
| % Growth | – | 100% | 50% | – |
| EPS Diluted | 0 | 0 | -0 | -0.001 |
| Weighted Avg Shares Out | 800,000 | 348,118 | 65,860 | 49,995 |
| Weighted Avg Shares Out Dil | 800,000 | 348,118 | 65,860 | 49,995 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $228 | $237 |
| EBITDA | -$1 | -$10 | $208 | -$31 |
| % Margin | – | -7.1% | 2,773.8% | – |